Myasthenia gravis with membranous nephropathy, successfully treated with extended total thymectomy

Internal Medicine

Volumn 39, Issue 6, 2000, Pages 490-494

  Matsuda, Masayuki ^a   Miki, Jun ^a   Tabata, Ken Ichi ^a   Ikezoe, Masaya ^a   Nishizawa, Nobuhiro ^a   Ishigame, Hiroki ^a  

^a Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

Author keywords

Anti acetylcholine receptor antibody; Hepatitis B virus carrier; Renal biopsy

Indexed keywords

ARTICLE; CASE REPORT; FEMALE; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; METHODOLOGY; MIDDLE AGED; MYASTHENIA GRAVIS; REMISSION; THYMECTOMY;

FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MIDDLE AGED; MYASTHENIA GRAVIS; REMISSION INDUCTION; THYMECTOMY;

EID: 0034202882     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.490     Document Type: Article

References (28)

1. Endoh M, Kaneshige H, Tomino Y, et al. IgA nephropathy associated with myasthenia gravis and scleritis. Tokai J Exp Clin Med 6: 421-425, 1981.
2. Scadding GK, Sweny P, Wilson SG, Havard CW, Newsom-Davis J. Glomerulonephritis, thymoma and myasthenia gravis. Q J Med 52: 187-193, 1983.
3. Miyazaki M, Kimura N, Imai K, et al. Association of IgA nephropathy and myasthenia gravis. Nephron 51: 402-404, 1989.
4. Chan PC, Lau CC, Cheng IK, Chan KW, Jones BM, Chan MK. Minimal change glomerulopathy in two patients after thymectomy. Singapore Med J 31: 46-47, 1990.
5. Innes A, Cotton RE, Burden RP. Association of IgA nephropathy and myasthenia gravis. Nephron 54: 354, 1990.
6. Haslam PJ, Proctor SJ, Goodship TH, Zouvani J. Immune complex glomerulonephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation. Nephrol Dial Transplant 8: 1390-1392, 1993.
7. Valli G, Fogazzi GB, Cappellari A, Rivolta E. Glomerulonephritis associated with myasthenia gravis. Am J Kidney Dis 31: 350-355, 1998.
8. Tomida C, Yamagata K, Ishizu T, et al. A case of nephrotic syndrome associated with myasthenia gravis and malignant thymoma. Nippon Jinzo Gakkai Shi 41: 77-82, 1999.
9. Drachman DB, Kuncl RW. Myasthenia gravis, in: Immunology of Neuromuscular Disease. Hohlfeld R, Ed. Kluwer Academic Publishers, Dordrecht, 1994: 165-207.
10. La Civita L, Zignego AL, Lombardini F, et al. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Rheumatol 23: 1641-1643, 1996.
11. Tsukada N, Koh CS, Owa M, Yanagisawa N. Chronic neuropathy associated with immune complexes of hepatitis B virus. J Neurol Sci 61: 193-210, 1983.
12. Tsukada N, Koh CS, Inoue A, Yanagisawa N. Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen. J Neurol Sci 77: 203-216, 1987.
13. McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R. Serum autoanitibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 3: 196-205, 1986.
14. Lai KN, Lai FM, Tam JS. Comparison of polyclonal and monoclonal antibodies in determination of glomerular deposits of hepatitis B virus antigens in hepatitis B virus-associated glomerulonephritides. Am J Clin Pathol 92: 159-165, 1989.
15. Lin CY. Hepatitis B virus-associated membraneous nephropathy. Clinical features, immunological profiles and outcome. Nephron 55: 37-44, 1990.
16. Takekoshi Y, Tochimaru H, Nagata Y, Itami N. Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy. Kidney Int Suppl 35: S34-S39, 1991.
17. Fazekas A, Komoly S, Bozsik B, Szobor A. Myasthenia gravis. Demonstration of membrane attack complex in muscle end-plates. Clin Neuropathol 5: 78-83, 1986.
18. Varsano S, Bruderman I, Bernheim JL, Rathaus M, Griffel B. Minimal-change nephropathy and malignant thymoma. Chest 77: 695-697, 1980.
19. Ogawa M, Ueda S, Ohto M, et al. Minimal change nephrotic syndrome developed after non-surgical treatment of a thymoma. Clin Nephrol 38: 171-172, 1992.
20. McDonald P, Kalra PA, Coward RA. Thymoma and minimal-change glomerulonephritis. Nephrol Dial Transplant 7: 357-359, 1992.
21. ) Posner MR, Prout MN, Berk S. Thymoma and the nephrotic syndrome. A report of a case. Cancer 45: 387-391, 1980.
22. Weinberg K, Parkman R. Age, the thymus, and T lymphocytes. N Engl J Med 332: 182-183, 1995.
23. Mevorach D, Perrot S, Buchanan NM, et al. Appearance of systemic lupus erythematosus after thymectomy. Four case reports and review of the literature. Lupus 4: 33-37, 1995.
24. Shoenfeld Y, Lorber M, Yucel T, Yazici H. Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis. Additional evidence for the kaleidoscope of autoimmunity. Lupus 6: 474-476, 1997.
25. Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 51: 270-276, 1997.
26. 4-mediated disease. Lancet 351: 670-671, 1998.
27. Holdsworth SR, Kitching AR, Tipping PG. Th 1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 55: 1198-1216, 1999.
28. Wijermans P, Oosterhuis HJ, Astaldi GC, Schellekens PT, Astaldi A. Influence of adult thymectomy on immunocompetence in patients with myasthenia gravis. J Immunol 124: 1977-1982, 1980.